What is TKL Research?
Established in 1944 and headquartered in Fair Lawn, New Jersey, TKL Research operates as a comprehensive clinical research organization. The firm provides critical support to the pharmaceutical, biotechnology, medical device, and consumer healthcare industries. By maintaining a robust infrastructure for clinical trials and product development, TKL Research has solidified its position as a trusted partner for global life sciences entities. Its longevity in the market serves as a testament to its adaptability and commitment to rigorous scientific standards, ensuring that clients can effectively bring innovative medical solutions to market with precision and compliance.
How much funding has TKL Research raised?
TKL Research has raised a total of $2.6M across 2 funding rounds:
Debt
$1M
Debt
$1.6M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.6M led by PPP
Key Investors in TKL Research
PPP
Public-Private Partnership
What's next for TKL Research?
Looking ahead, the recent capital allocation is expected to drive TKL Research toward enhanced technological integration and service diversification. As the clinical research sector faces increasing pressure for faster, data-driven outcomes, the firm is well-positioned to leverage its recent financing to upgrade its digital infrastructure and expand its therapeutic expertise. By prioritizing operational efficiency and maintaining its reputation for high-quality data management, TKL Research is poised to sustain its growth trajectory, ensuring it remains a preferred partner for organizations navigating the complexities of modern healthcare development and regulatory approval processes.
See full TKL Research company page
